This content is machine translated Symposium Interventional Cardiology Too much of a good thing or not enough? The Interventional Cardiology Symposium at the University Hospital Zurich was also dedicated to anticoagulants and antiplatelet agents. Here, the question was “one, two, or three?” As it turned out, the…
View Post 3 min This content is machine translated Advanced melanoma Pembrolizumab is superior to ipilimumab There is news on the KEYNOTE-006 study evaluating pembrolizumab (Keytruda®) for the treatment of advanced melanoma. The study was terminated early after the defined endpoints consisting of progression-free and overall…
View Post 5 min This content is machine translated Congress of the American Academy of Neurology Current developments in dementia research After years of unsuccessful trials with monoclonal antibodies directed against specific forms of beta-amyloid, a promising candidate for the treatment of Alzheimer’s dementia now appears to be available for the…
View Post 2 min This content is machine translated Psychological problems with cancer The impact on patient and family is enormous Cancer diseases repeatedly bring patients and their relatives to their psychological limits. To prevent individuals from harming themselves or their children from developing behavioral problems, it is essential to identify…
View Post 6 min This content is machine translated American Academy of Allergy, Asthma & Immunology 2015 Things are happening in the fight against peanut allergy Allergy to peanuts has been a highly topical issue in allergology for years: in the last decade, the prevalence in children in Western countries has doubled; moreover, peanut allergy is…
View Post 4 min This content is machine translated Gastrointestinal Cancers Symposium 2015 Advanced colorectal cancer – first and second line news. Two studies presented at the 2015 Gastrointestinal Cancers Symposium in San Francisco were dedicated to first- and second-line treatment of metastatic colorectal cancer. One was to determine whether the more…
View Post 3 min This content is machine translated Prostate cancer risk Bald or not, varied sex life is crucial Epidemiological studies on the association between androgenetic alopecia and risk of prostate cancer are conflicting. Now it has been shown again: Male hair loss is unsuitable as a risk marker.…
View Post 2 min This content is machine translated Metastatic colorectal cancer Does vitamin D put the brakes on tumors? Prospective analysis of a phase III trial of metastatic colorectal cancer shows that higher vitamin D levels provide better outcomes. Patients not only lived significantly longer, but also later became…
View Post 2 min This content is machine translated Oral mucositis during radiotherapy Does flushing with tricyclic antidepressant help? Oral mucositis may occur as a side effect of radiotherapy for head and neck tumors. This is frequent, sometimes extremely painful and clearly limits the therapeutic options. Pain-relieving medications are…
View Post 4 min This content is machine translated 10th Zurich Hypertension Day Does “ARNI” represent a new, blood pressure-lowering active principle? On January 15, 2015, the Zurich Hypertension Day was held for the tenth time at the University Hospital Zurich. Already five minutes before the start of the event, the large…
View Post 4 min This content is machine translated News from dermatooncology Melanoma with or without BRAF mutation – new therapies in the pipeline Data from two phase III trials (both from the research group led by Caroline Robert, MD, Institut Gustave Roussy in Villejuif, Paris) published earlier this year highlight the rapid development…
